The global mobile gamma cameras market size was valued at USD 57.8 Million in 2024 and is projected to reach USD 79.2 Million by 2033, growing at a CAGR of 3.39% during the forecast period of 2025-2033. This growth is driven by rising chronic disease prevalence, advancements in imaging technology, and increased demand for portable diagnostic devices. North America leads the market, driven by government healthcare initiatives and the adoption of these devices in oncology and cardiology. 

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Mobile Gamma Cameras Market Key Takeaways

• Current Market Size: USD 57.8 Million (2024)
• CAGR: 3.39% (2025-2033)
• Forecast Period: 2025-2033
• North America holds over 35.0% market share in 2024, leading the global market.
• The market is supported by the increasing incidence of cancer and cardiovascular diseases.
• Single-head mobile gamma cameras hold the largest product segment share at 62.9% in 2024, due to cost-effectiveness and versatility.
• Thyroid scanning dominates application segments because of the global prevalence of thyroid disorders.
• Hospitals represent the largest end-user segment with a 41.3% market share in 2024 due to their extensive infrastructure and patient volume.

Sample Request Link: 

https://www.imarcgroup.com/mobile-gamma-cameras-market/requestsample

Market Growth Factors

The global mobile gamma cameras market growth is strongly supported by the rising prevalence of chronic diseases. According to the WHO, noncommunicable diseases (NCDs) cause 41 Million deaths annually, accounting for 74% of all global fatalities. Cancer, being a leading cause of death with about 10 Million deaths in 2020, increases the demand for gamma camera devices, especially during radio-guided surgeries. The growing elderly population, a high-risk group for chronic diseases, also fuels demand for accessible diagnostic tools like mobile gamma cameras.

Advancements in imaging technology significantly drive the mobile gamma cameras market. Innovations such as solid-state detectors, high-energy collimators, and software integration enhance image quality and diagnostic speed. The integration of artificial intelligence and machine learning improves image interpretation accuracy, supporting early and precise diagnosis, particularly in oncology and cardiology. Healthcare providers increasingly adopt these technologies to enhance operational efficiency and patient outcomes.

The shift toward portable and point-of-care diagnostic solutions is another major growth driver. Unlike traditional stationary gamma cameras, mobile versions provide flexibility for bedside, outpatient, and emergency use. This mobility is crucial for critically ill patients or those with limited mobility. Additionally, mobile gamma cameras support decentralized healthcare by enabling real-time diagnostics in remote or resource-limited settings, reducing healthcare costs and improving access to advanced diagnostic services globally.

Market Segmentation

By Product:

• Single-head Mobile Gamma Cameras: Account for 62.9% market share in 2024, favored for cost-effectiveness, versatility, and suitability for various clinical applications including thyroid, bone, renal, and cardiac imaging.
• Dual-head Mobile Gamma Cameras: Not provided in source.
• Triple-head Mobile Gamma Cameras: Not provided in source.
• Handheld Mobile Gamma Camera: Not provided in source.

By Application:

• Cardiac Imaging: Not provided in source.
• Breast Imaging: Not provided in source.
• Thyroid Scanning: Dominates applications due to its critical role in diagnosing and monitoring thyroid disorders, offering precise visualization using radioactive isotope uptake. Portable cameras enhance accessibility in outpatient and rural settings.
• Kidney Scanning: Not provided in source.
• Intraoperative Imaging: Not provided in source.
• Brain Imaging: Not provided in source.
• Others: Not provided in source.

By End User:

• Hospitals: Largest segment with 41.3% market share in 2024, due to extensive infrastructure, large patient volume, and skilled professionals enabling diverse diagnostic needs.
• Ambulatory Surgical Centers: Not provided in source.
• Research Centers: Not provided in source.
• Imaging Centers and Clinics: Not provided in source.

Regional Insights

North America leads the global mobile gamma cameras market, holding over 35.0% share in 2024. The region benefits from advanced healthcare infrastructure, rapid adoption of modern medical technologies, and high prevalence of chronic diseases such as cancer and cardiovascular disorders. The aging population also drives demand for portable diagnostic solutions. The United States specifically accounts for 83.9% of North America's market due to increasing chronic disease burden, technological advancements, favorable reimbursement policies, and focus on early disease detection.

Recent Developments & News

• October 2024: Serac Imaging Systems announced initial findings on the clinical feasibility of Seracam®, a portable gamma-optical camera for sentinel lymph node imaging in breast cancer, presented at IPET 2024 in Vienna. Seracam® provides visual imaging alongside gamma detection, improving node localization.
• August 2024: Royal Shrewsbury Hospital launched a new gamma camera backed by a EUR 3.6 Million (USD 4 Million) investment by Shrewsbury and Telford NHS Trust, enhancing cancer and acute condition diagnostics with improved image quality and reduced waiting times.
• February 2024: M3D, Inc., based in Michigan, received investment from Michigan Rise Pre-Seed Fund III to advance gamma radiation detection cameras, with products targeting safety, compliance, and intraoperative surgery. The safety camera is expected for commercial release by mid-2024.

Key Players

• CMR Naviscan Corporation
• Crystal Photonics GmbH
• Mediso Ltd.
• MiE GmbH
• NUVIATech Instruments
• Oncovision
• Southern Scientific Ltd.
• Spectrum Dynamics Medical
• TTG Imaging Solutions

Get Custom Market Research Report for Your Business:

https://www.imarcgroup.com/request?type=report&id=5895&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302